Stay updated on Amifampridine in MuSK-MG Clinical Trial

Sign up to get notified when there's something new on the Amifampridine in MuSK-MG Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Amifampridine in MuSK-MG Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    The page now displays the completed Phase 3 study of amifampridine phosphate for myasthenia gravis, including its design, eligibility criteria, locations, outcome measures, and study documents.
    Difference
    48%
    Check dated 2026-11-08T15:11:51.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    The footer revision changed from v3.7.2 to v3.8.0; the page continues to show a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-01T16:13:49.000Z thumbnail image
  4. Check
    21 days ago
    Change Detected
    Summary
    A banner announces NIH’s transition from using “Artificial Intelligence” to “Super Intelligence” terminology under Executive Order 14434.
    Difference
    1%
    Check dated 2026-10-25T19:21:45.000Z thumbnail image
  5. Check
    28 days ago
    Change Detected
    Summary
    The footer revision label changes from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-18T22:36:28.000Z thumbnail image
  6. Check
    35 days ago
    Change Detected
    Summary
    The footer site revision changes from v3.7.0 to v3.7.1, while the study page continues to show a 403 error.
    Difference
    0.2%
    Check dated 2026-10-11T22:32:50.000Z thumbnail image
  7. Check
    56 days ago
    Change Detected
    Summary
    The study page now displays a 403 Forbidden error, replacing the usual study record content and preventing access to the study details.
    Difference
    18%
    Check dated 2026-09-20T22:14:26.000Z thumbnail image

Stay in the know with updates to Amifampridine in MuSK-MG Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Amifampridine in MuSK-MG Clinical Trial page.